癌症患者🈶光了_老虎社区_美港股上老虎 - 老虎社区

超富美少女

癌症患者🈶光了

@小虎AV：2030年前，癌症疫苗或将问世！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":662479045,"tweetId":"662479045","gmtCreate":1666742772887,"gmtModify":1666742775942,"author":{"id":3559265417743172,"idStr":"3559265417743172","authorId":3559265417743172,"authorIdStr":"3559265417743172","name":"超富美少女","avatar":"https://static.tigerbbs.com/7392e7e668ef54b7632379da408c4140","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":143,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>癌症患者🈶光了</p></body></html>","htmlText":"<html><head></head><body><p>癌症患者🈶光了</p></body></html>","text":"癌症患者🈶光了","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/662479045","repostId":662068280,"repostType":1,"repost":{"magic":2,"id":662068280,"tweetId":"662068280","gmtCreate":1666075648441,"gmtModify":1666075662325,"author":{"id":3514329116425907,"idStr":"3514329116425907","authorId":3514329116425907,"authorIdStr":"3514329116425907","name":"小虎AV","avatar":"https://static.tigerbbs.com/162e12f8dcec770ec19f66f2abb0d5db","vip":4,"userType":4,"introduction":"小虎视频搬运工，热衷吃瓜，偶尔正经，蟹蟹你这么好看还关注我","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":35378,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"2030年前，癌症疫苗或将问世！","html":"<html><head></head><body><p>当地时间10月16日，据《卫报》报道，德国生物技术公司BioNTech的创始人在采访时称，mRNA新冠疫苗技术可用于帮助摧毁癌细胞，当被问及基于mRNA的癌症疫苗何时可用于患者时，联合创始人萨欣表示，它们可能在2030年之前问世。 联合创始人图雷利称，将病毒不具感染性的刺突蛋白的遗传指令运送到人体内，被产生刺突蛋白的细胞接收，这些蛋白质或抗原能指导细胞器辅助激活自然免疫反应，告诉免疫系统的抗体和其他防御系统要搜索和攻击的目标。 BioNTech是欧洲最大生物技术独角兽，与美国辉瑞合作研发生产了mRNA新冠疫苗。[666]<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> <video tg-height=\"630\" tg-width=\"540\" webkit-playsinline=\"true\" poster=\"https://static.tigerbbs.com/e6da60fbe58aa2236aeb2433459ee36e\" controlslist=\"nodownload\" controls=\"\" playsinline=\"\"> \n <source src=\"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/82c285b0387702307298054172/aC5HGeVu3PQA.mp4\" type=\"video/mp4\"> \n</video></p></body></html>","htmlText":"<html><head></head><body><p>当地时间10月16日，据《卫报》报道，德国生物技术公司BioNTech的创始人在采访时称，mRNA新冠疫苗技术可用于帮助摧毁癌细胞，当被问及基于mRNA的癌症疫苗何时可用于患者时，联合创始人萨欣表示，它们可能在2030年之前问世。 联合创始人图雷利称，将病毒不具感染性的刺突蛋白的遗传指令运送到人体内，被产生刺突蛋白的细胞接收，这些蛋白质或抗原能指导细胞器辅助激活自然免疫反应，告诉免疫系统的抗体和其他防御系统要搜索和攻击的目标。 BioNTech是欧洲最大生物技术独角兽，与美国辉瑞合作研发生产了mRNA新冠疫苗。[666]<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> <video tg-height=\"630\" tg-width=\"540\" webkit-playsinline=\"true\" poster=\"https://static.tigerbbs.com/e6da60fbe58aa2236aeb2433459ee36e\" controlslist=\"nodownload\" controls=\"\" playsinline=\"\"> \n <source src=\"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/82c285b0387702307298054172/aC5HGeVu3PQA.mp4\" type=\"video/mp4\"> \n</video></p></body></html>","text":"当地时间10月16日，据《卫报》报道，德国生物技术公司BioNTech的创始人在采访时称，mRNA新冠疫苗技术可用于帮助摧毁癌细胞，当被问及基于mRNA的癌症疫苗何时可用于患者时，联合创始人萨欣表示，它们可能在2030年之前问世。 联合创始人图雷利称，将病毒不具感染性的刺突蛋白的遗传指令运送到人体内，被产生刺突蛋白的细胞接收，这些蛋白质或抗原能指导细胞器辅助激活自然免疫反应，告诉免疫系统的抗体和其他防御系统要搜索和攻击的目标。 BioNTech是欧洲最大生物技术独角兽，与美国辉瑞合作研发生产了mRNA新冠疫苗。[666]$辉瑞(PFE)$ $BioNTech SE(BNTX)$","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/662068280","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"a016acb6651843cf91da04aee3648224","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/82c285b0387702307298054172/aC5HGeVu3PQA.mp4","poster":"https://static.tigerbbs.com/e6da60fbe58aa2236aeb2433459ee36e","desc":""},"commentLimit":10,"symbols":["BNTX","PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":494,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":2067,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":14,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/662479045"}